| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Dominique Salmon, Pascale Trimoulet, Camille Gilbert, Caroline Solas, Eva Lafourcade, Julie Chas, Lionel Piroth, Karine Lacombe, Christine Katlama, Gilles Peytavin, Hugues Aumaitre, Laurent Alric, François Boué, Philippe Morlat, Isabelle Poizot-Martin, Eric Billaud, Eric Rosenthal, Alissa Naqvi, Patrick Miailhes, Firouzé Bani-Sadr, Laure Esterle, Maria-Patrizia Carrieri, François Dabis, Philippe Sogni and Linda Wittkop |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Inserm-ANRS (French National Institute for Health and Medical Research – ANRS/France REcherche Nord and Sud Sida-hiv Hépatites) |
|
|
| Corresponding Author |
Dominique Salmon, MD, PhD, Professor, Assistance Publique des Hôpitaux de Paris, Hôpitaux Universitaires Paris Centre, Hôpital Hôtel Dieu, Unité des Maladies infectieuses et tropicales, Sorbonne Paris Cité, 1 place du Parvis Notre-Dame, Paris 75004, France. dominique.salmon@aphp.fr |
| Key Words |
Human immunodeficiency virus; Hepatitis C virus; Direct-acting antiviral; Treatment virological failure; Resistant associated mutations |
| Core Tip |
In co-infected human immunodeficiency virus-hepatitis C virus (HCV) patients, after adjustment for age, sex, ribavirin use, HCV genotype and treatment duration, low platelets count was the only factor significantly associated with a higher risk of failure. |
| Publish Date |
2018-11-27 13:56 |
| Citation |
Salmon D, Trimoulet P, Gilbert C, Solas C, Lafourcade E, Chas J, Piroth L, Lacombe K, Katlama C, Peytavin G, Aumaitre H, Alric L, Boué F, Morlat P, Poizot-Martin I, Billaud E, Rosenthal E, Naqvi A, Miailhes P, Bani-Sadr F, Esterle L, Carrieri P, Dabis F, Sogni P; Linda Wittkop for the ANRS CO13 Hepavih study group. Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients. World J Hepatol 2018; 10(11): 856-866 |
| URL |
http://www.wjgnet.com/1948-5182/full/v10/i11/856.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v10.i11.856 |
